FDAFDA · Food and drugs·Recall number D-0223-2024
Tizanidine Tablets, USP 4mg, 150-count bottle, Rx only, Mfd. By: Dr. Reddy's Laboratories Limited, Srikakulam - 532 409 INDIA, NDC 55111-180-15
Published January 17, 2024 · Recall initiated: January 2, 2024
Status when published: Completed — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Foreign tablets/capsules - identified as tizanidine 2 mg tablets.
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- TIZANIDINE
- Manufacturer
- Dr. Reddy's Laboratories, Inc.
- Distributor
- USA Nationwide
- UPC
- 0355111180104
- Lot
- Lot #: T2304007, Exp 7/31/2026
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.